Special Issue "Pharmaceutical Manufacturing Process of Inhaled Drugs"
Deadline for manuscript submissions: closed (25 September 2023) | Viewed by 233
An inhalation preparation refers to a special dosage form that is administered with a special device, such that a drug acts on the lungs and exerts local or systemic effects through the deep part of the respiratory tract, cavities, mucous membranes, etc. It is often used in the treatment of respiratory diseases such as asthma and chronic obstructive pulmonary disease. The route of inhalation administration has the advantages of being non-invasive, a quick onset, less local metabolic enzymes, and localized drug delivery. According to different devices, it can be divided into powder inhalations (DPIs), metered inhalation aerosols (MDIs), and liquid preparations for inhalation. Additionally, there are inhalation sprays, among which DPIs, MDIs, and liquid preparations for inhalation are widely used. In recent years, with increasing air pollution and the aging of the population, the prevalence of respiratory diseases continues to rise, and inhalation drug delivery has become a method of drug delivery that has attracted much attention. In addition, inhalation formulations for the delivery of novel biologics for pulmonary disorders, infections, and cancer, such as mRNA, antibodies, and diagnostics, have received extensive attention from academia and industry.
The preparation methods of respirable particles include top-down techniques and bottom-up techniques. Traditional drug grinding methods include ball milling, colloid milling, hammer milling, and jet milling. In this Special Issue, we will focus on novel laboratory as well as industrial methods for formulating generic drugs and novel therapeutic cargos.
Dr. Qian Zhong
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- inhaled drug
- respiratory system
- spray drying
- spray freeze
- powder inhalation (DPI)
- metered inhalation aerosol (MDI)
- pulmonary diseases